A detailed history of Russell Investments Group, Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 2,764,800 shares of PFE stock, worth $77.4 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,764,800
Previous 2,936,333 5.84%
Holding current value
$77.4 Million
Previous $84.5 Million 9.24%
% of portfolio
0.12%
Previous 0.15%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $4.44 Million - $5.1 Million
-171,533 Reduced 5.84%
2,764,800 $76.7 Million
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $22.3 Million - $29 Million
-853,282 Reduced 22.52%
2,936,333 $84.5 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $15 Million - $17.5 Million
466,800 Added 14.05%
3,789,615 $126 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $9.41 Million - $10.9 Million
-260,427 Reduced 7.27%
3,322,815 $122 Million
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $27.2 Million - $35.5 Million
691,406 Added 23.91%
3,583,242 $146 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $1.86 Million - $2.43 Million
-44,539 Reduced 1.52%
2,891,836 $148 Million
Q3 2022

Nov 04, 2022

BUY
$43.76 - $53.42 $2.65 Million - $3.23 Million
60,546 Added 2.11%
2,936,375 $129 Million
Q2 2022

Jul 29, 2022

SELL
$46.53 - $55.17 $70.7 Million - $83.9 Million
-1,520,166 Reduced 34.58%
2,875,829 $151 Million
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $9.15 Million - $11.3 Million
-200,052 Reduced 4.35%
4,395,995 $228 Million
Q4 2021

Jan 21, 2022

SELL
$41.32 - $61.25 $13.8 Million - $20.4 Million
-332,980 Reduced 6.76%
4,596,047 $271 Million
Q3 2021

Nov 08, 2021

SELL
$39.25 - $50.42 $26.8 Million - $34.4 Million
-682,281 Reduced 12.16%
4,929,027 $212 Million
Q2 2021

Aug 04, 2021

SELL
$35.91 - $40.68 $12.1 Million - $13.7 Million
-337,088 Reduced 5.67%
5,611,308 $220 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $14.8 Million - $16.6 Million
-440,749 Reduced 6.9%
5,948,396 $215 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $45.3 Million - $57.6 Million
-1,352,582 Reduced 17.47%
6,389,145 $235 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $35.7 Million - $41.9 Million
-1,125,357 Reduced 12.69%
7,741,727 $283 Million
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $4.98 Million - $6.04 Million
165,221 Added 1.9%
8,867,084 $290 Million
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $21.2 Million - $30.3 Million
-785,496 Reduced 8.28%
8,701,863 $284 Million
Q4 2019

Jan 29, 2020

SELL
$32.92 - $37.36 $21 Million - $23.9 Million
-638,891 Reduced 6.31%
9,487,359 $371 Million
Q3 2019

Nov 01, 2019

SELL
$32.49 - $42.13 $21.4 Million - $27.8 Million
-659,585 Reduced 6.12%
10,126,250 $365 Million
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $57.1 Million - $64.1 Million
-1,543,072 Reduced 12.52%
10,785,835 $468 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $81.4 Million - $89.5 Million
2,171,762 Added 21.38%
12,328,907 $523 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $14.9 Million - $16.9 Million
-386,064 Reduced 3.66%
10,157,145 $441 Million
Q3 2018

Oct 26, 2018

SELL
$34.47 - $41.81 $23.9 Million - $28.9 Million
-692,132 Reduced 6.16%
10,543,209 $464 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $109 Million - $116 Million
-3,303,026 Reduced 22.72%
11,235,341 $408 Million
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $8.6 Million - $9.98 Million
269,531 Added 1.89%
14,538,367 $515 Million
Q4 2017

Feb 06, 2018

BUY
$33.26 - $35.29 $34.2 Million - $36.3 Million
1,027,380 Added 7.76%
14,268,836 $519 Million
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $410 Million - $452 Million
13,241,456
13,241,456 $473 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.